Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Non-Current Assets (2016 - 2026)

Collegium Pharmaceutical has reported Non-Current Assets over the past 11 years, most recently at $965.4 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 18.28% year-over-year to $965.4 million; the TTM value through Dec 2025 reached $4.1 billion, up 17.63%, while the annual FY2025 figure was $965.4 million, 18.28% down from the prior year.
  • Non-Current Assets for Q4 2025 was $965.4 million at Collegium Pharmaceutical, down from $993.5 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $1.2 billion in Q3 2024 and troughed at $349.8 million in Q1 2021.
  • A 5-year average of $750.2 million and a median of $735.1 million in 2022 define the central range for Non-Current Assets.
  • Biggest five-year swings in Non-Current Assets: soared 152.32% in 2022 and later dropped 19.72% in 2024.
  • Year by year, Non-Current Assets stood at $376.5 million in 2021, then skyrocketed by 100.29% to $754.1 million in 2022, then fell by 19.68% to $605.7 million in 2023, then skyrocketed by 95.03% to $1.2 billion in 2024, then dropped by 18.28% to $965.4 million in 2025.
  • Business Quant data shows Non-Current Assets for COLL at $965.4 million in Q4 2025, $993.5 million in Q3 2025, and $1.0 billion in Q2 2025.